07:00 , Aug 7, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Infectious disease Hendra virus glycoprotein G; Nipah virus glycoprotein G Monkey studies suggest the human mAb m102.4 could be used to treat Nipah and...
07:00 , May 14, 2012 |  BC Week In Review  |  Company News

Catalent Pharma, Profectus infectious, biomanufacturing news

Profectus said it received a $5.6 million grant from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to conduct preclinical development of a vaccine using soluble Hendra virus glycoprotein G for use in humans...